Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription
Mitsuru Okubo, Tomohiro Itonaga, Tatsuhiko Zama, Ryuji Mikami, Yukinori Okada, Tsubasa Kawamoto, Shiho Wada, Shinji Sugahara, Kazuhiro Saito · 2026
Read Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription by Mitsuru Okubo, Tomohiro Itonaga, Tatsuhiko Zama, Ryuji Mikami, Yukinori Okada, Tsubasa Kawamoto, Shiho Wada, Shinji Sugahara, Kazuhiro Saito (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13223005.txt.
Description
Mitsuru Okubo and eight co-authors compare two ways of prescribing dose in focused lung radiotherapy. Their 2026 study reviews patients with early lung cancer who cannot have surgery. One dosing style aims at the tumor's center point; the newer style covers a volume. Which style serves patients better was unsettled.
The team reviewed eighty-eight patients treated between twenty fifteen and twenty twenty-four. Volume-based plans covered the target better and put higher doses where aimed. They also spared more healthy lung tissue. Three-year survival and local control ran markedly higher in the volume group. Side effects are compared as well, making the case for the volume style.
Catalog record
| CREATOR | Mitsuru Okubo, Tomohiro Itonaga, Tatsuhiko Zama, Ryuji Mikami, Yukinori Okada, Tsubasa Kawamoto, Shiho Wada, Shinji Sugahara, Kazuhiro Saito |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |